Hematopoietic Stem Cell TransplantationBone Marrow TransplantationTransplantation, HomologousHematopoietic Stem CellsStem Cell TransplantationGraft vs Host DiseaseTransplantation, AutologousBone MarrowTransplantation ConditioningStem CellsBone Marrow CellsHematologic NeoplasmsTransplantation ChimeraWhole-Body IrradiationPeripheral Blood Stem Cell TransplantationTissue DonorsGraft SurvivalHematopoiesisLeukemiaBusulfanHistocompatibility TestingLiver TransplantationHistocompatibilityTreatment OutcomeAntigens, CD34Cell DifferentiationAnemia, AplasticRecurrenceHematopoietic Stem Cell MobilizationCord Blood Stem Cell TransplantationMice, Inbred C57BLCombined Modality TherapyColony-Forming Units AssayRetrospective StudiesLeukemia, Myeloid, AcuteCyclophosphamideCell LineageImmunosuppressive AgentsRemission InductionTime FactorsTransplantation, IsogeneicGraft vs Leukemia EffectKidney TransplantationHepatic Veno-Occlusive DiseaseMyeloablative AgonistsBone and BonesChimerismHematologic DiseasesFlow CytometryHLA AntigensLeukemia, Myelogenous, Chronic, BCR-ABL PositiveTransplantation ImmunologyMyelodysplastic SyndromesCells, CulturedPrecursor Cell Lymphoblastic Leukemia-LymphomaBone Marrow PurgingMesenchymal Stem Cell TransplantationSevere Combined ImmunodeficiencyCell TransplantationMultiple MyelomaSurvival AnalysisGranulocyte Colony-Stimulating FactorSurvival RateGraft RejectionGraft vs Tumor EffectAdult Stem CellsLymphocyte TransfusionLymphocyte DepletionMelphalanDisease-Free SurvivalAcute DiseaseT-LymphocytesLymphoma, Non-HodgkinLeukemia, MyeloidStem Cell NicheImmunosuppressionCell SeparationBone Marrow DiseasesRadiation ChimeraFetal BloodAntineoplastic Combined Chemotherapy ProtocolsHeart TransplantationCell ProliferationCytomegalovirus InfectionsSiblingsFollow-Up StudiesVidarabineEmbryonic Stem CellsAntilymphocyte SerumMesenchymal Stromal CellsUnrelated DonorsMultipotent Stem CellsLung TransplantationSalvage TherapyOrgan TransplantationStem Cell FactorNeural Stem CellsCytarabineCyclosporineAntigens, CD